Ondexxya for Intravenous Injection 200mg Drug Use Result Investigation (All Case Investigation)

Clinical trial NCT05454787 · RECRUITING

Trial details

NCT number: NCT05454787
Sponsor: AstraZeneca
Status: RECRUITING
Study type: OBSERVATIONAL

Life Threatening Bleeding Factor Xa Inhibitor

Start date: 2022-06-02
Primary completion: 2026-10-31
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.